Tofacitinib for ulcerative colitis: A promising treatment option

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

716

Figures (1-1)

114

Sum=858

Publishing Process of This Article

Item

Count

Browse

Download

Sum=69

Oct 28, 2024 (publication date) through Jan 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Oct 28, 2024; 30(40): 4386-4392
Published online Oct 28, 2024. doi: 10.3748/wjg.v30.i40.4386

Figure 1 The flowchart of large-scale, multicenter and prospective clinical studies.

Citation: Han ZQ, Wen LN. Tofacitinib for ulcerative colitis: A promising treatment option. World J Gastroenterol 2024; 30(40): 4386-4392
URL: https://www.wjgnet.com/1007-9327/full/v30/i40/4386.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i40.4386